SUBSCRIBE
SUBSCRIBE
News   FDA

Merck & Co., Inc. Says FDA Approves New AIDS Treatment

October 12, 2007 | 
1 min read
WASHINGTON (Reuters) - U.S. regulators approved a new AIDS treatment made by Merck & Co, the first in a new class of drugs aimed at preventing replication of the virus, Merck said on Friday.
FDA Approvals
Merck & Co. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Dorval, Quebec, Canada - September 3, 2021: Novartis Pharmaceuticals Canada Inc. head office building in Dorval, Quebec, Canada. Novartis is a global healthcare company based in Switzerland.
Approvals
Novartis Expands Spinal Muscular Atrophy Gene Therapy Market With FDA’s Itvisma Greenlight
November 25, 2025
 · 
3 min read
 · 
Heather McKenzie
Richard Pazdur
FDA
Pazdur Questions Safety, Legality of FDA’s Expedited Drug Approval Programs
November 25, 2025
 · 
2 min read
 · 
Tristan Manalac
FDA commissioner Marty Makary speaking on a Youtube video, wearing a dark suit and a blue tie
Regulatory
FDA Frictions Continue as White House Denies Promotion to Makary’s Aide
November 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Symbolic image: Sign 180 degree turn
FDA
FDA Reversals Send UniQure, Biohaven, Capricor, More Into a ‘Tailspin’
November 24, 2025
 · 
7 min read
 · 
Heather McKenzie